This Week in Psychedelics - 9.24.21

Cannabis

• Switzerland’s Zurich to Begin Recreational Cannabis Trial in 2022 (High Times)

• U.S. House Approves SAFE Banking Act as Part of Military Spending Bill in Historic Vote (High Times)

• Green Party in Finland Calls for End of Prohibition (High Times)

• This company is smuggling tons of legal cannabis into streets, whistleblower alleges (Leafly)

• California State Fair Will Host Marijuana Competition For The First Time At 2022 Event, Officials Announce (Marijuana Moment)

• Connecticut: Qualified Patients Can Begin Home Cultivating Cannabis Next Week (NORML)

• Rhode Island Lawmakers Are ‘Very Close’ On Marijuana Legalization Deal Ahead Of Possible Special Session, Top Senator Says (Marijuana Moment)

• Lessons the Psychedelics Industry Can Learn From the Cannabis Market Bubble (Lucid News)

• Pennsylvania Senators Discuss Bill To Provide DUI Protections For Medical Marijuana Patients (Marijuana Moment)

• VA sending mixed messages for vets about cannabis use to treat PTSD (Arizona Mirror)

• Delaware: Governor Signs Measure Amending Cannabis Penalties for Minors (NORML)

• FBI Clarifies That Using Marijuana More Than 24 Times Disqualifies Would-Be Agents (Marijuana Moment)

• Former Massachusetts Mayor Sentenced for Extortion (High Times)

• Controlling cannabis and the classification of Delta-8 THC (Reuters)

• Eaze launches California program to bring free medical cannabis to low-income patients (Greenway Magazine)

• Mississippi Lawmakers Reach Deal On Medical Marijuana Legalization, Plan To Request Special Session (Marijuana Moment)

• For Chronic Pain Sufferers, Cannabis "May Be a Source of Hope" (Green Entrepreneur)

• Full-Page Washington Post Ad Calls For Marijuana Prisoner’s Freedom While Celebs Make Money In Industry (Marijuana Moment)

• Can Cannabis Help Your Gut? (TIME)

• Florida Marijuana Activists File New Legalization Initiative For 2022 Ballot Following Supreme Court Defeats (Marijuana Moment)

• Oklahoma Activists Finalize Language For Two 2022 Marijuana Ballot Initiatives (Marijuana Moment)

• Nebraska Cannabis Association launches as state's first lobbying group for marijuana-based businesses (York News-Times)

Magic Mushrooms

• Psilocybin Study for Tobacco Gets Federal Funding (Truffle Report)

• Thousands attend first-ever psychedelic shroom festival in Ann Arbor (MLive.com)

• Canadian Coalition Submits Draft for Legal Psilocybin Therapy (Truffle Report)

• Happy Global Magic Mushroom Day (9/20) for Psilocybin Fans (CelebStoner)

• Nine Perfect Strangers's Portrayal of Psilocybin Could Derail Progress in Researching Psychedelic Use for Mental Health (Teen Vogue)

• Shroom Delivery is Now a Thing (DoubleBlind)

• Magic Mushrooms May Be the Biggest Advance in Treating Depression Since Prozac (Newsweek)

• Former GOP Congresswoman Touts Psilocybin As Treatment For Alcoholism (Marijuana Moment)

• Psyched Wellness Initiates a Clinical Sleep Study on Humans for a Structure/Function Claim For AME-1 (Psilocybin Alpha)

• Amanita muscaria – A Fresh Look at An Iconic Mushroom (Psychedelic Science Review)

• The 25 Best U.S. Counties for Mushroom Foragers (moveBuddha)

• MindMed and Liechti Lab Provide Results from their Psilocybin R&D Collaboration (Psilocybin Alpha)

• Eversio Wellness Harvests Its First Legally Grown Psychoactive Mushrooms (Yahoo! Finance)

MDMA

• Awakn Life Sciences Acquires Exclusive Rights to MDMA Research from Imperial College London (Psilocybin Alpha)

DMT

• Small Pharma Successfully Completes Phase I Clinical Trial of DMT in Combination with Supportive Psychotherapy (Psilocybin Alpha)

5-MeO-DMT

• I Wanted Ego Death. This Powerful Psychedelic Gave It To Me. (BuzzFeed News)

• Lexston Initiates Research and Development Project Using Psychedelic Compound 5-Me0-DMT (TheNewswire)

Mescaline

• Mescaline, Veganism, and Schopenhauer’s Philosophy (Sam Woolfe)

Iboga

• DemeRx Doses First Subject in Phase 1/2a Study of DMX-1002 (Ibogaine) in Opioid Use Disorder (Psilocybin Alpha)

Salvia Divinorum

• Salvia Divinorum and Kratom Combination – What You Must Know About It (IRN Post)

Novel Psychoactive Substances

• Are Prodrugs the Next Wave of Psychedelic Drug Development? (Psychedelic Science Review)

• Mindset Pharma Announces Further Preclinical Results Demonstrating Strong Efficacy and Improved Safety Profile for its 5-MeO-DMT-Inspired Drug Candidate, MSP-4018 (Psilocybin Alpha)

• Tryp Therapeutics Submits IND Application for Phase 2a Clinical Trial in Eating Disorders (Psilocybin Alpha)

• Clearmind Medicine Partners with The Hebrew University to Develop Novel Psychedelic Drug (Yahoo! Finance)

• Mydecine Files MYCO-003 Final Patent Application and Reports Positive Preclinical Data (Psilocybin Alpha)

Synthetic Cannabinoids

• Spice is significantly more harmful than marijuana (International Business Times)

• New Study Comparing Plant-Derived and Synthetic CBD Efficacy Opens Door to Exciting Medical Uses of Cannabidiol (Yahoo! Finance)

Nitrous Oxide

• TikTok Is Hosting Ads for ‘Whipped Cream’. But It’s Actually Nitrous Oxide (VICE)

Ketamine

• Delic signs US$10 million merger deal to become top psychedelic wellness chain in the U.S. (Canadian Lawyer)

• Turning Everyday Therapist Offices into Ketamine Clinics (Lucid News)

• Statistical model defines ketamine anesthesia’s effects on the brain (MIT News)

• Is A Ketamine Infusion Covered By Insurance? (Healing Maps)

Miscellaneous

• Companies are Getting Rid of Drug Tests Because They Can’t Find Enough Workers (VICE)

• Class A drug possession ‘effectively decriminalised’ in Scotland (The Times)

• Hamilton Morris Hired by Psilocybin Startup COMPASS Pathways, Ends "Hamilton's Pharmacopeia" On Vice (Psymposia)

• Italian Advocates Collect 500,000 Signatures for Decriminalization of Cannabis and Psychoactive Substances (High Times)

• Psychedelics Are a Billion-Dollar Business, and No One Can Agree Who Should Control It (VICE)

• Meet Microdosing TikTok—And Why the Community Matters (Psychedelics Today)

• More Michigan Cities Look to Decriminalize Psychedelics (Truffle Report)

• The Michigan Poison and Drug Information Center issues notification about effects and risks of using psychedelic substances (Today@Wayne)

• Criticism of Awakn Treatment Model as Second Clinic Opens for Treating Addiction (TalkingDrugs)

• Psychedelic Patents: Nature, IP Law, & Exclusion (Truffle Report)

• How To Come Down From A High: Navigating the Downslope of a Trip (DoubleBlind)

• Armed With Two Patents, Psycheceutical Plans To Transform Psychedelic Drug Delivery (Forbes)

• Psychedelic Water founder looks to new legal era for powerful drugs (The Washington Times)

• Mycrodose Therapeutics Successfully Completes Oversubscribed Private Placement to Expand Existing Patent Portfolio of Breakthrough Advanced Drug Delivery Technologies (Psilocybin Alpha)

• Why Bristol Uni is taking a more progressive stance on drugs (The Bristol Cable)

• Numinus Completes Acquisition of Neurology Centre of Toronto (Psilocybin Alpha)

• The Removal of the Ecuadorian Drug Possession Table: A Major Government Mistake (TalkingDrugs)

• ATMA Journey Centers Offer Regulated Health Care Professionals a Means to Incorporate Psychedelic-Assisted Psychotherapy Into Their Practice (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 7.23.21

Cannabis

• Cops Will No Longer Bust People for Weed at New York Airports (MERRY JANE)

• Redlining in Cannabis is Cutting Off Opportunity For Black People. (Chicago Defender)

• Medical Marijuana Patient Sues Polis Over New MMJ Laws (Westword)

• The Pernicious Myth of Fentanyl-Laced Cannabis (Filter)

• Virginia's “Marijuana Martyr” Is Now Smoking Legal Weed 48 Years After His Arrest (MERRY JANE)

• Another North Carolina Senate Committee Approves Medical Marijuana Legalization Bill (Marijuana Moment)

• Study: Cannabis Use Not Linked to Motivation Loss (NORML)

• Missouri Marijuana Activists File Legalization Initiatives For 2022 As Other Groups Prepare Separate Measures (Marijuana Moment)

• High-Potency THC Concentrates Are Just As Safe As Regular-Potency Weed, More Data Shows (MERRY JANE)

• Mississippi Lawmakers Aim To Pass Medical Marijuana Bill In August Special Session After Ballot Measure Blocked By Court (Marijuana Moment)

• The future of cannabis is female: Gen Z women are fastest-growing consumers of legal weed (NBC News)

LSD

• Performance-enhancing psychedelics: Can LSD make you better at sport? (New Atlas)

• Mississippi city settles over case of man who had taken LSD, then died after police used Taser to restrain him (Magnolia State Live)

Magic Mushrooms

• The Magic Mushroom Map shows likely spots for psilocybin-containing mushrooms (Boing Boing)

• The Other Magic Mushroom: Why a Canadian Startup is Suddenly Interested in the Fungus From Super Mario (Discover Magazine)

• Mouse Study Reveals New Details on Psilocybin’s Rewiring of the Brain (Psychedelic Science Review)

• Expert: Psilocybin Treatment May Support Patients With Obesity Who Have Tried Everything, Need Further Support (Pharmacy Times)

• Tryp Therapeutics Announces Plans for Phase 2a Clinical Trial for Fibromyalgia with the University of Michigan (Psilocybin Alpha)

MDMA

• AOC Promotes Research On Benefits Of Psychedelics Like Psilocybin And MDMA With New Amendment (Marijuana Moment)

• MDMA as a Potential Treatment for PTSD (Reality Sandwich)

DMT

• Could DMT Sweep Existing Treatments for Depression Aside? (MarketWatch)

Ayahuasca

• The Good, The Bad, and the Soul: Drug Interactions and Ayahuasca with Ben Malcolm (EntheoNation)

5-MeO-DMT

• Sonora’s traditional toad medicine ‘removes the madness from your mind’ (Mexico News Daily)

Iboga

• Lamar Odom Reveals ‘Ibogaine’ Use To Treat Drug Addiction In Explosive New Interview (The Blast)

Novel Psychoactive Substances

• Mydecine Expands Portfolio of Novel Molecules Filing New Patent for MDMA-like Compounds (Psilocybin Alpha)

Nitrous Oxide

• Is Nitrous Oxide a Psychedelic Drug? (Psychedelic Science Review)

Ketamine

• Ireland trials use of ketamine to treat depression (Irish Central)

• Braxia Scientific says ketamine treatment now covered by insurance for Canadian military and RCMP veterans (Proactive Investors)

• Sublingual Ketamine Is Safe and Effective for Management of Chronic Nonmalignant Pain (Clinical Pain Advisor)

• Ketamine Therapy and Addiction Risk Management: Part II (Truffle Report)

• PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation (Psilocybin Alpha)

• Mindful Use of Nitrous Oxide: How to be a Connoisseur of Getting High (Maps of the Mind)

• What Neurotransmitters Does Ketamine Affect Most In The Brain? (Healing Maps)

Miscellaneous

• Is It Too Early to Invest in Psychedelic Stocks? (Nasdaq)

• Why Mindfulness Practitioners are Better Positioned to Trip on Psychedelics (DoubleBlind)

• How Freaks of Color Shaped Psychedelia (Lucid News)

• From Screening to Integration: Harm Reduction in Psychedelic Research (Psychedelic Science Review)

• Psychedelic Surrender (Maps of the Mind)

• Psychedelics Are Not a Mental Health Panacea (Sam Woolfe)

• Towards a More Rational and Compassionate Drug Policy (Dr. Bronner's)

• Psychedelic Activity Menus: Having Options for Your Session (Maps of the Mind)

• What Is Depth Psychology and How Does It Relate to Psychedelics? (Psychedelics Today)

• Are Potentially Legal Psychedelics Safe For Pregnant Women? (Healing Maps)

• Psychedelic Therapeutics Startup Cybin To List On NYSE’s Small Cap Market (Forbes)

• Could Psychedelics Help Prevent Mental Health Problems? (Kahpi)

• Working at Legal Psychedelic Retreats Around The World (Maps of the Mind)

• Psychedelics and Queerness (Reality Sandwich)

• What International Drug Users Remembrance Day Means to Me (Filter)

• Chelsea Osmond: Linking the Past and Future of the Psychedelic Renaissance (Chacruna)

• Creating Music Playlists for Psychedelic Journeys (Maps of the Mind)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 4.30.21

Cannabis

• Montana Bill To Implement Marijuana Legalization Heads To Governor’s Desk (Marijuana Moment)

• Texas Lawmakers Approve Marijuana And Psychedelics Reform Bills (Marijuana Moment)

• Philadelphia: City Council Votes to Prohibit Pre-Employment Drug Screening for Cannabis (NORML)

• GOP Congressman’s Bill Would Protect Marijuana Consumers’ 2nd Amendment Rights (Marijuana Moment)

• Minnesota Marijuana Legalization Bill Clears Ninth House Committee On Path To Floor (Marijuana Moment)

• Louisiana Lawmakers Approve Marijuana Legalization Bill In Committee (Marijuana Moment)

• South Dakota Supreme Court Hears Arguments in Litigation Challenging State’s Voter-Approved Marijuana Legalization Initiative (NORML)

• Bolsonaro’s Cabinet Crusade Against Cannabis is Racist and Classist (TalkingDrugs)

• Pennsylvania Marijuana Poll Shows Highest-Ever Support For Legalization (Marijuana Moment)

LSD

• CEO Of $2 Billion Startup Fired After Experimenting With LSD At Work (Forbes)

Magic Mushrooms

• Maine Proposal Would Legalize Psilocybin Mushroom Therapy For Adults, No Medical Diagnosis Needed (Marijuana Moment)

• How an expert psilocybin tester chooses award-winning mushrooms (Inverse)

• Hawaii Legislature Seeks Marijuana Exemption From DEA While Senate Requests Legal Psilocybin Plan (Marijuana Moment)

• Revive Therapeutics Files for FDA Orphan Drug Designation for Psilocybin in Traumatic Brain Injury (Psilocybin Alpha)

• Numinus Announces Phase 1 Clinical Trial of Natural Psilocybin Mushroom Extraction Prepared at Company Lab (Psilocybin Alpha)

• Red Light Holland and Halo Collective Create Red Light Oregon, Inc. – Forwarding Intentions to Enter Oregon Medicinal Psychedelic Market (Psilocybin Alpha)

MDMA

• MDMA-Assisted Therapy for Alcohol Addiction (Spirit Pharmacist)

• Bupropion and MDMA, Risky Combination? (Spirit Pharmacist)

DMT

• PharmaDrug Announces First FDA Orphan Drug Designation of DMT for the Prevention of Ischemia-Reperfusion Injury from Organ Transplantation (Psilocybin Alpha)

Ayahuasca

• Spain’s (Second to) Last Ayahuasca Trial (ICEERS)

Novel Psychoactive Substances

• Non-hallucinogenic psychedelics: scientists close in on compound (The Guardian)

• Mindset Pharma Announces Positive Preclinical Results of Its Proprietary Next Generation DMT & 5-MeO-DMT Compounds (Psilocybin Alpha)

• Eliminating Bad Trips Through Minor Tryptamines (Truffle Report)

• Cybin Selects Alcohol Use Disorder Indication for Psychedelic Molecule CYB003 (Psilocybin Alpha)

Synthetic Cannabinoids

• 'Rising rates' of synthetic marijuana in Iowa prisons prompts investigation (Des Moines Register)

Ketamine

• Bill to regulate ketamine used during police calls passes House committee (Sentinel Colorado)

• Bexson Biomedical Granted USPTO Patent On Proprietary Ketamine Formulation (Psilocybin Alpha)

• PharmaTher Expands Patent Portfolio with Filing of U.S. Patent Application for Ketamine and Repurposing of Psychedelics with panaceAI™ (Psilocybin Alpha)

Miscellaneous

• MindMed Becomes Second Psychedelic Drug Development Company to List on the Nasdaq (Psilocybin Alpha)

• Scientists are Using AI to Develop New Psychedelic Drugs (DoubleBlind)

• UCSF Launches New Psychedelic Research Division (Benzinga)

• Drug Possession To Be A Misdemeanor—For Now—Under Washington State Bill Headed To Governor’s Desk (Marijuana Moment)

• Psychedelic drugs without the trip? This sensor could help seek them out (Nature)

• Should Society Legalize Psychedelics? A Breakdown of the Intelligence Squared Debate (Psychedelics Today)

• Native Tribes Should Have More Say in the Psychedelic Movement (Green Entrepreneur)

• This Brain Imaging Device Could Impact Understanding Psychedelic Trips (Healing Maps)

• COMPASS Pathways announces pricing of public offering (Psilocybin Alpha)

• How To Talk With Your Kids About Psychedelics (Psychedelics Today)

• Why Psychedelics, Big in the 1960s, Are Drawing New Interest Now (Bloomberg)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

A Biotech Startup Won a Patent to Combine Elements of Weed and Psychedelics

Troy Farah, writing for Future Human:

Whether aiming to enhance spiritual growth or brighten the music at Lollapalooza, people have been combining cannabis and psilocybin “magic” mushrooms recreationally for ages. But a small biotech startup called CaaMTech Inc. just became the first to patent the idea.

The patent covers a whole range of cannabinoids — chemical compounds produced by marijuana plants, such as THC or CBD — mixed with a bevy of chemicals related to psilocybin mushrooms. It details myriad formulations, including dried powder, pills, gummies, and edibles, with a blanket of proposed applications for psychological disorders. The company, based in the Seattle suburb of Issaquah, hopes investors will want to license these formulations, which each combine a cannabinoid with a psilocybin derivative, either to treat mental health or entertain a yet-to-exist recreational market. The U.S. Patent and Trademark Office awarded the patent in mid-January.

---

Post Permalink

This Week in Psychedelics - 1.22.21

Cannabis

• France launches public consultation on legalising cannabis (France24)

• UFC ditch marijuana ban but fighters warned to ‘temper enthusiasm’ after Usada rule change (The Independent)

• Biden Taps Marijuana Legalization Supporter To Lead Democratic National Committee (Marijuana Moment)

• American Medical Association Asks Court To Overturn Medical Marijuana Vote In Mississippi (Marijuana Moment)

• Arizona: Adult Use Marijuana Sales On Track to Begin This Month (NORML)

• This Michigan marijuana dispensary is giving free weed to anyone who got the COVID-19 vaccine (Detroit Metro Times)

• Trump Grants Clemency To Marijuana Prisoners On Last Day In Office (Marijuana Moment)

• Study: Nearly Half of Medical Cannabis Users Cease Using Opioids for Pain After Twelve Months (NORML)

• Congressman Files First Federal Marijuana Reform Bill Of 2021 (Marijuana Moment)

• Could Medical Cannabis Help with the Treatment of Movement Disorders? (Canex)

• Latest Canadian cannabis recalls include melting vape pens, moldy bud (Marijuana Business Daily)

• Virginia Marijuana Legalization Bill Approved By Senate Committee, With Home Cultivation Provisions Intact (Marijuana Moment)

• “Game changer” for the sector: First cannabis company expected to list on LSE next month (Cannabis Health News)

• Police Find 1st 'Cannabis Factory' In London's Financial District, Destroy 826 Plants (NPR)

• Hash landing: New Zealand police ditch annual helicopter hunt for cannabis dens (The Guardian)

• Phytol cited as potentially dangerous cannabis vape ingredient (Marijuana Business Daily)

• Study: Cannabis Use Associated with Reduced Alcohol Intake Among Treatment-Seeking Drinkers (NORML)

• Research establishes antibiotic potential for cannabis molecule (ScienceDaily)

• Women who use cannabis may have harder time conceiving (Healio)

• How Some THC Is Legal — For Now (Rolling Stone)

Magic Mushrooms

• Florida Lawmaker Introducing Psilocybin Mushroom Legalization (Forbes)

• Unique magic mushroom microdosing study to begin in Australia (New Atlas)

• How Mixing Mushrooms and MDMA Affects Your Body and Brain (VICE)

• Patient hopes Canada will introduce regulations for treatment with 'magic mushrooms' (CTV News)

• BC Craft Supply Co Announces Letter of Intent with Psilocybin Research and Development Company Ava Pathways (Globe Newswire)

MDMA

• MindMed Announces the Start of the First-Ever Clinical Trial Combining MDMA and LSD (Psilocybin Alpha)

Ayahuasca

• Insight into Ayahuasca’s Antidepressant Effects (Psychedelic Science Review)

5-MeO-DMT

• New Toad Venom Compound Synthesized for Clinical Use: 5-MeO-DMT Succinate (Psychedelic Science Review)

Synthetic Cannabinoids

• NCSA: Synthetic cannabis a cause for concern (Loop Barbados)

Ketamine

• Ketamine Clinicians Publish Ethical Guidelines to Raise Treatment Standards (Lucid News)

• Colorado officials resume review of ketamine program after Elijah McClain's death (CNN)

• PharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine Formulation Targeting Mental Health, Neurological and Pain Disorders (Psilocybin Alpha)

Miscellaneous

• Icelandic Government Proposes Drug Decriminalisation (The Reykjavik Grapevine)

• Peter Thiel-backed psychedelics start-up targets schizophrenia ahead of IPO (CNBC)

• Psychedelic Therapy Schools Are Popping Up Like Mushrooms (Bloomberg)

• The Biden Administration and Drug Policy: Expectation Versus Reality (Filter)

• North American Psychedelics Index Published: Which Companies Will Be in the First Psychedelic ETF? (Psilocybin Alpha)

• A New Supreme Court RFRA Ruling May Be a Boon to Psychedelic Religions (Chacruna)

• Senator wants to 'lock in' 2020 drug laws (Idaho Press)

• NeonMind Lists on the Frankfurt Stock Exchange (Psilocybin Alpha)

• Is Psychedelic Medicine the Antidote to Anti-Black White Racism in the US? (Chacruna)

• The Therapeutic Potential of Psychedelics and Nature Explored in New Study (Lucid News)

• Psychedelic Authoritarianism Harm Reduction: “QAnon Shaman” Edition (Psymposia)

• Here’s What’s Missing From Conversations About Psychedelic Integration (DoubleBlind)

• Attorney General Merrick Garland a Disheartening Prospect (Filter)

• Dopamine Release and Duration of Action: Rules of Thumb to Predict Addictive Potential of Phenethylamines (Spirit Pharmacist)

• Ergot in Canada: A Lost Tradition? (Chacruna)

• BetterLife Pharma Is Developing Second Generation Psychedelics: Drugs That Leave Out The Trip (Forbes)

• Former Defence Force chief Chris Barrie supports increased accessibility of psychedelic drugs (The Canberra Times)

• Could Biden Make His Country’s Global Drug War Even More Imperialist? (Filter)

• What Will The Psychedelics Space Look Like In 2021? Experts Weigh In (Yahoo! Finance)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.